DJIA 17,841.89 121.97 0.69%
NASDAQ 5,146.76 38.10 0.75%
S&P 500 2,096.34 15.93 0.77%
market minute promo

Regeneron Pharmaceuticals (NASDAQ: REGN)

545.10 0.60 (0.11%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

REGN $545.10 0.11%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $549.25
Previous Close $544.50
Daily Range $536.30 - $550.32
52-Week Range $383.87 - $605.93
Market Cap $56.7B
P/E Ratio 107.61
Dividend (Yield) $0.00 (0.0%)
Volume 428,532
Average Daily Volume 773,798
Current FY EPS $9.80




Drug Makers

Regeneron Pharmaceuticals (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website:

News & Commentary

CVS Health Plays Favorites with New Cholesterol Drugs

Amid shifting pharmacy benefit manager policies, Amgen has a chance to dominate the market for next-generation cholesterol drugs.

Stock Market News for December 01, 2015

Repatha Vs. Praluent: Will Amgen's Patents Decide The Race For The Prevailing PCSK9 Inhibitor?

3 Stocks Dragging The Drugs Industry Downward

Monday Sector Laggards: Healthcare, Services

Jim Cramer's 'Mad Money' Recap: How to Become an Even Better Investor

Regeneron, Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent Injection Fully Enrolle

Regeneron, Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent Injection Fully Enrolled

3 Stocks to Buy and Hold for the Next Decade

Our contributors highlight three remarkably strong companies to hold for the long term.

Weekly CFO Sells Highlights: Facebook, Fitbit, Regeneron Pharmaceuticals

5 Things Amgen, Inc. Wants You to Know

Amgen may have crushed Wall Street's Q3 forecast, but if you didn't listen to its quarterly conference call, then you probably missed out on these key points concerning its long-term outlook.

See More REGN News...

REGN's Top Competitors

REGN $545.10 (0.11%)
Current stock: REGN
AMGN $160.94 (-0.10%)
Current stock: AMGN
GILD $105.33 (-0.59%)
Current stock: GILD
BIIB $288.80 (0.68%)
Current stock: BIIB